Reme-D, Egyptian Molecular Diagnostics Startup, Raises $1.45M Pre-Series A To Scale Africa Operations
Egyptian healthtech startup Reme-D has raised $1.45 million in a Pre-Series A round led by Anara Impact Capital, with Global Innovation Fund and Africa Health Ventures also participating. The Cairo-based molecular diagnostics company develops affordable, temperature-resilient tests for tuberculosis, HIV, hepatitis, and HPV, targeting healthcare gaps across Africa and other underserved markets. Since launching in […]




